Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Oxybuprocaine is an anesthetic.1 Intrathecal administration of oxybuprocaine reduces motor function, decreases righting behaviors in the placement test, and increases latency to paw withdrawal in the hot plate test in rats (ED50s = 0.43, 0.5, and 0.31 µmol/kg, respectively). Topical application of oxybuprocaine (0.4% w/v) reduces corneal sensitivity in the corneal touch test in dogs.2 Formulations containing oxybuprocaine have been used to induce anesthesia prior to ocular surgery.
WARNING This product is not for human or veterinary use.
1. Intrathecal oxybuprocaine and proxymetacaine produced potent and long-
2. Degree and duration of corneal anesthesia after topical application of 0.4% oxybuprocaine hydrochloride ophthalmic solution in ophthalmically normal dogs. Am. J. Vet. Res. 74(10), 1321-1326 (2013).